Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

MemoryCare.com Names the Best Facilities for Senior Memory Care in Kent, WA


News Image

MemoryCare.com, a comprehensive resource for caregivers and older adults living with memory impairment, has announced the Best Memory Care Facilities in Kent, Washington. The guide identifies 5 memory care communities based on location, access to experts, facility features and amenities.

According to the Alzheimer’s Association, 5.6 million people age 65 and older are living with Alzheimer’s dementia. In Kent, the number of senior deaths related to Alzheimer’s increased by 30 percent between 2013 and 2017. Memory care facilities offer activities and therapies to help delay or halt cognitive decline. They also give family members and caregivers peace of mind by providing a safe environment for loved ones.

“There’s a high demand for quality memory care all across our nation; specifically, in cities like Kent, which experienced a rapid increase in Alzheimer’s related deaths,” says Joyce Collins. “MemoryCare.com provides free resources to help families find the best facilities.”

Through hours of research and an intensive selection process, MemoryCare.com was designed to help caregivers find effective solutions for their loved ones. The website not only highlights the best facilities in the city, it also shares information about cost, reviews from residents, type of care offered and more. For a detailed listing of the Best Memory Care Facilities in Kent, WA, please visit https://www.memorycare.com/kent-wa-facilities/

2020 Best Memory Care Facilities in Kent, WA (in alphabetical order)

Arbor Village Senior Living

Phone: (253) 856-1600

Address: 24121 116th Ave. SE., Kent, WA 98030

Web: arborvillage.us/

Chateau Valley Center

Phone: (425) 336-4257

Address: 4450 Davis Ave. S., Renton, WA 98055

Web: chateau-valley-center.com/

Normandy Park Assisted Living

Phone: (206) 539-1629

Address: 16625 1st Ave. S., Normandy Park, WA 98148

Web: normandyparksl.com/

The Meridian at Stone Creek

Phone: (253) 214-3078

Address: 1111 S. 376th St., Milton, WA 98354

Web: pacificaseniorliving.com

The Weatherly Inn

Phone: (253) 630-7496

Address: 15101 SE. 272nd St., Kent, WA 98042

Web: weatherlyinn.com/

ABOUT MEMORYCARE.COM

MemoryCare.com provides tools and resources to help adults living with memory impairment and their families. The online guide uses data-driven research and expert evaluations to identify the best facilities across the nation. The MemoryCare.com team includes medical and elder care professionals as well as board of directors. For more information, visit https://www.memorycare.com/.

Share article on social media or email:

Spartan Bioscience investigating ways to use their rapid, on-site DNA testing technology to help with the COVID-19 outbreak


The Spartan Cube

The Spartan Cube

“We have world-leading portable DNA testing technology but funding will be key to developing a rapid COVID-19 test.”- Paul Lem, M.D. and CEO of Spartan Bioscience

Spartan Bioscience, a Canadian biotechnology company and world leader in on-demand DNA testing(1), has developed a rapid, sample-to-result DNA testing platform that is designed for in-field diagnostic testing. Spartan’s technology has regulatory approvals worldwide, including FDA 510(k), European CE IVD Mark, and Health Canada. Spartan’s customers include leading organizations such as Mayo Clinic, the Centers for Disease Control and Prevention (CDC), New York State Department of Health, and Fortune 500 companies.

Spartan’s Cube platform would be ideal for fast and portable detection of COVID-19 because it can be deployed in non-laboratory settings such as airports, cruise ships, military bases, and other critical points of entry. The CDC has developed a COVID-19 DNA test and Spartan is currently exploring how to perform the test on its platform.

Spartan Bioscience is led by CEO, Paul Lem, an infectious disease doctor by training. Lem says that Spartan has been exploring how the company’s technology could be applied to COVID-19 and thinks a commercial test could be available within 8 to 12 weeks.

“As a private company, it comes down to funding,” says Lem. “We have world-leading portable DNA testing technology but funding will be key to developing a rapid COVID-19 test.”

About Spartan Bioscience

Spartan Bioscience is a leader in rapid DNA testing. Spartan is bringing complete sample-to-result DNA testing systems to fields such as precision medicine, environmental water testing, and infectious diseases. Spartan’s technology fully integrates DNA collection, extraction, and analysis, with an intuitive interface that is easy to operate. In the same way that mainframe computers gave way to personal computers, high-throughput DNA testing systems in central labs are giving way to decentralized devices. For the first time, healthcare providers and their patients can get DNA results on demand. For more information, please visit our website at: http://www.spartanbio.com.

For media inquiries, please contact:

Molly Kett, Director of Communications

media@spartanbio.com

1. Roberts JD et al. (2012). Lancet. 379:1705–11.

Share article on social media or email:

Project HOPE’s Coronavirus Response Expands to Support America’s Health Workers and Underserved Communities


Project HOPE logo

“As a global humanitarian organization, Project HOPE’s mandate is always to respond where the need is greatest, and now the need is massive right here at home,” said Rabih Torbay, President and CEO of Project HOPE.

As confirmed cases of COVID-19 rapidly increase in the United States, Project HOPE is ramping up to support America’s response efforts.

“As a global humanitarian organization, Project HOPE’s mandate is always to respond where the need is greatest, and now the need is massive right here at home,” said Rabih Torbay, President and CEO of Project HOPE. “We will be supporting America’s health workers as they work to save lives and fight the virus’s spread. And because one case can ignite a cluster, we’re also looking at ways we can support underserved and marginalized communities that are unlikely to seek testing.”

For more than 60 years, Project HOPE has worked on the front lines of the world’s health challenges, partnering hand-in-hand with communities, health care workers, and public health systems to ensure sustainable change. When needs exceed local capacity, Project HOPE has used its global expertise to tackle health-related issues in the United States, particularly in response to large natural disasters that critically affect health and well-being. For example, in 2017, Project HOPE responded to three major hurricanes – Harvey, Irma, and Maria – by sending medical volunteers to Texas, Florida, and the U.S. territory of Puerto Rico.

Project HOPE has been responding to the COVID-19 pandemic since the outbreak began. Since early February 2020, Project HOPE’s team on the ground in China has been providing critical support and equipment to frontline health workers treating patients and working to contain the virus. Project HOPE has delivered nearly 5 million facemasks as well as isolation gowns, protective coveralls, exam gloves, and other protective gear to hospitals that have screened and treated thousands of patients in China.

As the virus spread and became a global pandemic, Project HOPE began preparing to provide vital training and contact tracing in high-risk countries like North Macedonia, Kosovo, Ethiopia, Indonesia, and Colombia. In Puerto Rico – which is still reeling in the wake of Hurricane Maria as well as the earthquakes earlier this year – Project HOPE is working with partners on the ground to support community-based response efforts where health facilities remain stretched.

For more information on Project HOPE’s response to the coronavirus outbreak, visit http://www.projecthope.org.

Share article on social media or email:

Multi-food Oral Immunotherapy Found to Be Safe and Effective


AAAAI Logo

“Instead of cycling through multiple six to 10 month single food courses, we can safely combine multiple foods into one OIT course.” – Hugh H. Windom, MD, FAAAAI

Combining multiple food allergies into a single oral immunotherapy course is as safe and effective as single food immunotherapy, according to research scheduled for presentation at the 2020 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting before it was cancelled due to the situation with coronavirus disease 2019 (COVID-19).

A retrospective review was used to complete the study, looking at patients who started peanut oral immunotherapy (OIT) from April 2014 through September 2018 and patients undergoing multi-food OIT from February 2015 through September 2018. Diagnostic allergy testing was encouraged every year and reactions requiring epinephrine were recorded.

Multi-food patients were treated with an average of 2.4 foods (with individual options ranging from two to four foods in one OIT course). Patients on both forms of therapy were placed on a dosing schedule with the eventual goal of reaching maintenance dosing. According to the study, 85% of peanut OIT patients reached their maintenance dose compared to 80% of those on multi-food OIT. The median amount of time it took to reach the maintenance dose was 245 days for peanut OIT and 231 days for multi-food OIT patients.

“What we discovered is that instead of cycling through multiple six to 10 month single food courses, we can safely combine multiple foods into one OIT course,” said Hugh H. Windom, MD, FAAAAI. “This gives patients with multiple food allergies more options when it comes to treatment plans.”

Epinephrine was used in 13% of patients undergoing peanut OIT and 8% of multi-food OIT patients during the first year of treatment. This is consistent with published reports, and there were no reports of severe anaphylaxis. The most common reason for stopping OIT in both groups was non-compliance and delayed gastrointestinal symptoms. This further indicates that overall, there were little differences in effectiveness and safety when comparing single food OIT to multi-food OIT.

Visit aaaai.org to learn more about OIT. This research was published in an online supplement to The Journal of Allergy and Clinical Immunology.

The American Academy of Allergy, Asthma & Immunology (AAAAI) represents allergists, asthma specialists, clinical immunologists, allied health professionals and others with a special interest in the research and treatment of allergic and immunologic diseases. Established in 1943, the AAAAI has over 7,000 members in the United States, Canada and 72 other countries. The AAAAI’s Find an Allergist/Immunologist service is a trusted resource to help you find a specialist close to home.

Share article on social media or email:

Sunknowledge Proposes A Redundancy Plan in Medical Billing


“For any operational stand still Sunknowledge proposes a disaster management plan”

Healthcare Providers are going to face shortage of staff in the coming days in a volatile market place! High rates of employment, growing burden on profits and revenue, declining mode of Medicare payments, lack of skilled resources and rising volumes in billing are improving the scope of the medical billing industry.

The US medical billing outsourcing market justifiably is expected to maintain a CAGR of 11% and reach $8 billion by 2026. A redundancy / disaster management plan is going to be important for healthcare providers right from extending care as well as managing everyday medical billing mandates.

Sunknowledge as a healthcare services company has made a useful presence in the medical billing landscape by working with prominent payers and providers across the country over the last decade.

A key member of their leadership team observed, “We offer a reliable redundancy/ disaster management plan for our clients. Setting benchmark by offering state of the art solutions in front/ back end medical billing to top names across the healthcare space, we extend a redundancy plan with an experienced team of medical billers offering dedicated support , customized reporting best practices. Sunknowledge ensures HIPAA compliance standards and deliver support with consistency and trust. We can deliver you support during an operational standstill.”

The company also has been involved in AR & collections related activities for several hospitals that include reaching out to insurance payers regarding status of submitted claims and following up on denials, under payments and appeals.

They are helping major insurance companies in claims adjudication services for hospitals, nursing homes, long term care, physician practices and Home Medical Equipment providers. Sunknowledge intends to continue assistance in resource migration activities to meet their client’s project deadlines during any crisis.

For Media Inquiries, Contact –

Ronnie Hastings

Director of Business Development

Sunknowledge Services Inc.

Contact Number: +1-646-661-7853

Email Id: Ronnie.Hastings(at)sunknowledge.com

Share article on social media or email:

M3 Global Research Acquires Manthan’s Healthcare Market Research Division


“The addition of m360 Research significantly advances M3 Global Research’s growth aspirations for 2020 and beyond,” said Anton Richter, CEO, M3 Global Research.

Global Healthcare Market Research Leader Adds Manthan’s Research Services to its Growing Global Portfolio

M3 Global Research today announced the acquisition of Manthan’s healthcare market research business. This bold move facilitates further growth for M3 and consolidates its position as the leading healthcare market research provider.

Headquartered in Bangalore, India, with offices in USA, Singapore, and Dubai, Manthan applies sophisticated analytics applications to generate high-quality insights and consumer intelligence. Its healthcare division will be rebranded after the acquisition as m360 Research. This strategic acquisition brings to M3 the m360 Research m-panels, a global panel community of over one million healthcare professionals across over 30 countries, as well as its innovative, technology-driven research services.

The new m360 Research brand reinforces the research services element of Manthan’s existing offering, as well as their legacy of innovative approaches. It will become a wholly owned subsidiary of the M3 Group, which now operates seven market research companies globally. m360 Research brings to M3 a best-in-class Canadian panel to complement M3 Global Research’s current offering across Europe, Nordics, Asia Pacific and The Americas, where its US domestic panel will be notably boosted by the acquisition.

“The addition of m360 Research significantly advances M3 Global Research’s growth aspirations for 2020 and beyond” said Anton Richter, CEO, M3 Global Research. “We’re especially enthusiastic about leveraging the power of m360 Research’s extensive platform and innovative research services to enhance our offering to existing clients, resulting in true ‘next generation’ healthcare market research.”

m360 Research CEO Mohit Kataria on the acquisition: “We are delighted to join the market leader, which will mean significant inward investment and additional resources for m360 Research. We look forward to being able to realise our ambitions to diversify revenue streams whilst continuing to provide innovative research solutions for our clients.”

m360 Research’s existing healthcare management team will continue to provide uninterrupted coverage to clients during the transition. This continuity of service provision extends to all areas of the business, and across all internal teams.

Sanjib Khemka, VP-Finance said, “We think M3 Group is the right partner to take m360 Research to next level. This transaction has created confidence with both employees and customers.”

For more information contact Sue Krause, Snr Marketing Director, M3 Global Research – skrause@usa.m3.com

About the M3 Group: The M3 Group operates in the US, Asia, and Europe with over 5.8 million physician members globally via its physician websites which include mdlinx.com, m3.com, research.m3.com, doctors.net.uk, medigate.net, medlive.cn, and m3india.in. M3 Inc. is a publicly traded company on the Tokyo Stock Exchange (jp:2413) with subsidiaries in major markets including USA, UK, France, Japan, China, and India. The M3 Group provides services to healthcare and the life science industry. In addition to market research, these services include medical education, ethical drug promotion, clinical development, job recruitment, and clinic appointment services. M3 has offices in Japan, UK, France, Germany, Spain, USA, Sweden, China, South Korea, and India.

About m360 Research: m360 Research is a global research partner to the life sciences industry, enabling researchers and marketers to connect with healthcare professionals. Its services include building research specific custom specialist communities, bulletin boards, collection and analysis of structured and unstructured data. m360 Research uses a cutting edge omni-channel approach backed by advanced panel analytics to ensure that clients benefit from expert insight, delivered quickly and cost-effectively.    

Share article on social media or email:

Balboa Capital Takes Steps to Keep its Employees Safe During the COVID-19 Pandemic


small business loans balboa capital

Small business owners and equipment vendors can rest assured in knowing that we are at 100% capacity and ready to assist them.

In the wake of the COVID-19 pandemic, Balboa Capital, a leading online lender that specializes in small business loans and equipment financing, has developed and enacted business continuity plans to help ensure the health of its employees and the communities in which they live.

“As a technology-driven lender, providing our in-office employees and remote workers with the latest tools, resources, and mission-critical applications necessary to serve our customers and vendor partners is something that we have been doing for many years,” said Robert Rasmussen, Chief Operating Officer at Balboa Capital. “As a result, we were well prepared for the prospect of a completely mobile workforce long before the recent coronavirus outbreak.”

Mr. Rasmussen said that Balboa Capital acted quickly to enable all of its employees to work remotely, and at optimum efficiency. “We made significant capital investments in IT equipment, mobile technology, and bank-level security technology that enable our entire workforce to work remotely. Employees in every department can access our suite of in-office resources and applications securely, and they can communicate with each other via telephone, chat, and video.”

“We know this is a rapidly evolving situation, and we are staying on top of the new information and recommendations coming from the CDC and the U.S. Department of State,” said Mr. Rasmussen.

About Balboa Capital

Balboa Capital is a technology-driven financing company that provides business owners with fast, hassle-free solutions to fuel their growth and success. The company specializes in small business loans, equipment financing, commercial financing, equipment vendor financing, and franchise financing. Balboa Capital developed an intuitive online platform that simplifies the entire financing process. Calculators provide instant estimates, applications can be completed and submitted in a matter of minutes, and sophisticated credit scoring technology provides instant decisions. To learn more, visit https://www.balboacapital.com.

Share article on social media or email:

Kajeet’s SmartBus™ Wi-Fi Grant Enables Austin Independent School District to Connect its 534 School Bus Fleet with Mobile Education Broadband™


“We’ve already seen the positive impacts of our Kajeet SmartBus Wi-Fi in school districts across the country, but this exciting partnership will give us irrefutable empirical evidence of its widespread impact in education,” says Daniel Neal, Founder and CEO of Kajeet.

Kajeet® has awarded the Austin Independent School District a grant to install 534 Kajeet SmartBus™ WiFi routers on their entire school bus fleet. The grant, valued at over $600,000, will be used to equip Austin school buses with Education Broadband to support the district’s COVID-19 plans, as well as to provide Wi-Fi access that keeps students on task on traditional bus routes, field trips, activities and athletic trips throughout the 2020-2021 Academic Year.

Although the grantmaking process began months before the COVID-19 outbreak, the award will figure significantly in the district’s remote online learning plans. “As we prepare for the possibility of extended school closures, we know that an Internet connection is a lifeline and a learning link for our students,” says Kevin Schwartz, Chief Technology Officer for Austin Independent School District. “Austin ISD will be deploying many of our 500+ Kajeet Wi-Fi/Internet enabled school buses to locations around our school district so that students can connect using our district Chromebooks.”

Under the terms of the award, both Kajeet and Austin ISD agreed to jointly deploy, promote, monitor, evaluate, and report on the impact of patented Kajeet SmartBus Wi-Fi as it relates to utilization rates, improvements to homework completion rates, student satisfaction, driver satisfaction, and reduction in disciplinary incidents, among other key performance measures. These metrics and more, planned before the recent COVID-19 outbreak, will be evaluated throughout the coming school year.

“We’ve already seen the positive impacts of our Kajeet SmartBus Wi-Fi in school districts across the country, but this exciting partnership—the largest deployment of our SmartBus Wi-Fi program in a single fleet—will give us irrefutable empirical evidence of its widespread impact in education, both enabling students to connect beyond the classroom and keeping them even safer on the school bus and as they disembark,” says Daniel Neal, Founder and CEO of Kajeet. “We’re especially pleased that the SmartBus Wi-Fi will be an essential component of Austin ISD’s COVID-19 response plans, since our underlying mission as a company has always been to provide safe, equitable mobile broadband access for students.”

Kajeet SmartBus Wi-Fi has been deployed in more than 285 school bus fleets across the United States and Canada across 6 major LTE networks, extending broadband access for all riders and enabling buses and other school vehicles to be used for additional connectivity for special activities, sporting events, field trips, and at community locations.

Share article on social media or email:

ThunderCat Technology, LLC forms partnership with UV Angel, Inc. to fight the spread of Coronavirus


News Image

ThunderCat Technology, LLC has formed a partnership with UV Angel Inc., a leader in pathogen control, to fight the spread of Coronavirus disease [COVID-19]. Headquartered in Grand Haven, Michigan, UV Angel uses patented ultraviolet light technology platforms to reduce harmful pathogens on surfaces and in the air.

“We believe rapid deployment of UV Angel technology in hospitals around the country can provide immediate support to our healthcare workers on the frontlines of the fight against bacteria, fungus and viruses like COVID-19,” said Tom Byrne, CEO of UV Angel. “As we’ve seen in Italy, China and elsewhere, healthcare workers are at significant risk from this disease. While there are no treatment silver bullets, it’s critical we provide them as many layers of protection as we can to help keep them safe and in the fight.”

UV Angel’s technology platform, including – UV Angel Air and UV Angel Adapt – provide health care workers crucial new tools in the fight against infectious diseases, by reducing and treating airborne and surface pathogens.

To combat the spread of viruses and other pathogens in the air, UV Angel Air is installed by replacing existing ceiling panels of patient rooms, emergency departments, and many other critical areas within healthcare facilities. To help prevent the spread of viruses and other pathogens on surfaces, UV Angel Adapt identifies interactions, detects potential contamination and treats keyboards, touch panels and other high-touch surfaces. All devices detect and report in real-time.

UV Angel has been on the forefront of discussions about COVID-19. The Chief Science and Medical Affairs Officer of UV Angel, Dr. Linda Lee, recently contributed to a live Q&A answering the nation’s most pressing questions in regards to COVID-19.

The partnership with ThunderCat Technology, LLC represents an integrated supply chain, representing suppliers, manufacturers, operations management, quality control and distribution to the recipient. ThunderCat Technology is a Service-Disabled Veteran-Owned Small Business that delivers technology products to Government organizations, education institutions, and commercial companies.

As the premier supplier of technology, ThunderCat Technology is the recipient of numerous awards and accolades. At the center of it all is ThunderCat Technology’s motto: “To make the United States a better and safer place for all Americans.” Where others have sacrificed much to bring us to today, it is now our turn. On behalf of ThunderCat Technology, UV Angel and numerous other partners, we will be resolute, and we will prevail.

Institutions and agencies are encouraged to contact the Corona Response Team at CoronaResponse@thundercattech.com .

THUNDERCAT CONTACT    

Greg Stolhand

571-328-8802

gstolhand@thundercattech.com

UV ANGEL CONTACT    

Megan McCarl

Lambert

(231) 670-5340

mmccarl@lambert.com

Share article on social media or email:

How to Effectively Communicate with FDA Regulators, Upcoming Webinar Hosted by Xtalks


Xtalks Life Science Webinars

Join Virginia Cox, JD – Senior Consultant and Lead, 3D Communications and Adam George, PharmD – Senior Consultant and Lead, 3D Communications in a live webinar on Thursday, April 09, 2020 at 12pm EDT (NA) (5pm BST/UK).

3D Communications has spent two decades preparing companies for FDA pre-submission and Advisory Committee meetings. During this time, 3D has developed “Top 10 Rules” to help make the journey smoother for clients and help them effectively hit their target.

In this webinar, 3D experts will discuss some of the common mistakes that sponsors make in their communications with regulators – and some time-tested rules which apply across all types of regulatory meetings.

These mistakes include:

  • Going into meetings without a thorough understanding of the regulatory precedent of their review division
  • Not having a clear strategy on a “win” for the interaction
  • Not adequately preparing
  • 3D Communications provides proven tactics that can be used to help companies communicate effectively with regulators so that meetings are productive and successful.

For more information or to register for this event, visit How to Effectively Communicate with FDA Regulators.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks, visit http://xtalks.com.

For information about hosting a webinar, visit http://xtalks.com/why-host-a-webinar/.

Share article on social media or email: